Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)
11. Dezember 2024 07:00 ET
|
Nusano, Inc.
VALENCIA, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced it will host a virtual key opinion leader (KOL) panel...
Nusano and GlyTherix Announce Lutetium-177 Supply Agreement
09. Dezember 2024 07:00 ET
|
Nusano, Inc.
VALENCIA, Calif. and SYDNEY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix), an Australian targeted...
Nusano Names Medical Radioisotopes Advisory Board
03. Dezember 2024 07:00 ET
|
Nusano, Inc.
VALENCIA, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced the creation of a Medical Radioisotopes Advisory Board....
Nusano to Present at William Blair Virtual Radiopharmaceuticals Event
12. November 2024 07:00 ET
|
Nusano, Inc.
VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William...
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
17. Oktober 2024 07:00 ET
|
Nusano, Inc.
VALENCIA, Calif. and TEL AVIV, Israel, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology...
Nusano Presenting at Industry Events in October
07. Oktober 2024 08:00 ET
|
Nusano, Inc.
VALENCIA, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in...
Nusano Adds to Executive Leadership Team in Advance of 2025 Commercialization
03. Oktober 2024 08:00 ET
|
Nusano, Inc.
VALENCIA, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced the addition of two executives to support...
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes
01. Oktober 2024 08:00 ET
|
Nusano, Inc.
VALENCIA, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of radioisotopes, today announced a Series C financing round with funding commitments...
Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024
20. Juni 2024 08:00 ET
|
Nusano, Inc.
VALENCIA, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced it will host a virtual event titled “Office Hours:...
Nusano Names D. Scott Holbrook as Chairman of its Board
07. Juni 2024 08:00 ET
|
Nusano, Inc.
VALENCIA, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced industry veteran D. Scott Holbrook as chairman...